DNA hydroxymethylation changes in response to spinal cord damage in a multiple sclerosis mouse model

Area of Science:

• Neuroscience
• Epigenetics
• Immunology

Background:

• Myelin repair is crucial for neurological function.
• DNA 5-hydroxymethylcytosine (5hmC) is an epigenetic modification implicated in various biological processes.
• Experimental autoimmune encephalomyelitis (EAE) is a mouse model for studying demyelinating diseases like multiple sclerosis.

Purpose of the Study:

• To investigate the role of DNA 5-hydroxymethylcytosine (5hmC) in myelin repair within the EAE mouse model.
• To explore the regulatory relationship between 5hmC and Brain-Derived Neurotrophic Factor (BDNF) in the context of EAE.
• To assess the therapeutic potential of modulating 5hmC levels for myelin repair.

Main Methods:

• Detection of DNA 5hmC levels and associated enzymes in EAE mouse spinal cord tissues.
• Assessment of global 5hmC modification, Tet1, and Tet2 expression.
• Measurement of BDNF protein and mRNA levels.
• Evaluation of the effects of Vitamin C (a Tet co-factor) on 5hmC, BDNF, and neurological deficits.

Main Results:

• Global 5hmC, Tet1, and Tet2 levels were significantly decreased in EAE mice.
• BDNF protein and mRNA levels were reduced and strongly correlated with BDNF 5hmC levels.
• Vitamin C administration increased global DNA 5hmC, enhanced BDNF 5hmC modification and protein levels, and ameliorated neurological deficits in EAE mice.

Conclusions:

• Tet protein-mediated 5hmC modifications are critical in EAE-induced myelin damage.
• Targeting epigenetic modifications, specifically 5hmC, presents a potential therapeutic strategy for multiple sclerosis and related demyelinating conditions.